AgomAb Therapeutics NV

AGMB

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0002020932

SEC filings (opens in a new tab)

No open-market purchases or sales by AgomAb Therapeutics NV insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $337.0M in total; no superinvestor holds it.

Superinvestors holding AGMB, Q2 2026

See all superinvestors

No superinvestor reported holding AGMB in Q2 2026.